We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

32 hedge funds and large institutions have $919K invested in AIM ImmunoTech in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

7% more funds holding

Funds holding: 30 → 32 (+2)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

62% less capital invested

Capital invested by funds: $2.43M → $919K (-$1.51M)

Holders
32
Holders Change
+2
Holders Change %
+6.67%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TSS
Two Sigma Securities
New York
+$16.6K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$8.88K
3
Verition Fund Management
Verition Fund Management
Connecticut
+$4.19K
4
Renaissance Technologies
Renaissance Technologies
New York
+$4.01K
5
BBA
Baader Bank Aktiengesellschaft
Germany
+$3.12K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$1.17M
2
Citadel Advisors
Citadel Advisors
Florida
-$23K
3
VF
Virtu Financial
New York
-$15.3K
4
XT
XTX Topco
Cayman Islands
-$3.89K
5
BCM
Bridgeway Capital Management
Texas
-$2.97K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$394K – – –
BlackRock
2
BlackRock
New York
$138K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$91.9K – – –
Citadel Advisors
4
Citadel Advisors
Florida
$71.1K -$23K -989 -22%
Renaissance Technologies
5
Renaissance Technologies
New York
$51.6K +$4.01K +172 +7%
State Street
6
State Street
Massachusetts
$34.3K – – –
Verition Fund Management
7
Verition Fund Management
Connecticut
$33.9K +$4.19K +180 +12%
Northern Trust
8
Northern Trust
Illinois
$16.9K – – –
Morgan Stanley
9
Morgan Stanley
New York
$15.1K -$1.86K -80 -9%
TSS
10
Two Sigma Securities
New York
$14.1K +$16.6K +714 New
XT
11
XTX Topco
Cayman Islands
$9.74K -$3.89K -167 -25%
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$7.53K +$8.88K +381 New
VF
13
Virtu Financial
New York
$7K -$15.3K -655 -64%
SWM
14
SeaCrest Wealth Management
New York
$6.94K – – –
HF
15
HRT Financial
New York
$6K -$722 -31 -9%
CAPTRUST Financial Advisors
16
CAPTRUST Financial Advisors
North Carolina
$3.96K – – –
TRCT
17
Tower Research Capital (TRC)
New York
$2.91K -$140 -6 -4%
CB
18
Community Bank
New York
$2.51K – – –
DBRC
19
D.B. Root & Company
Pennsylvania
$2.39K – – –
BBA
20
Baader Bank Aktiengesellschaft
Germany
$2.37K +$3.12K +134 New
TCM
21
Traynor Capital Management
Pennsylvania
$2.33K – – –
Corient Private Wealth
22
Corient Private Wealth
Florida
$2K +$23 +1 +1%
HWM
23
HB Wealth Management
Georgia
$1.98K +$2.33K +100 New
Osaic Holdings
24
Osaic Holdings
Arizona
$200 – – –
HI
25
Hoey Investments
Pennsylvania
$198 – – –
1
2

AIM Hedge Fund Activity: Q4 2024 in Review

32 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q4 2024, worth a combined $919K — down 62% from $2.43M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new AIM positions and 3 closed out — a net gain of 2 holders — while 4 added to existing stakes and 6 trimmed.

The largest buyer was Two Sigma Securities, opening a new position worth an estimated $16.6K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.17M sold.

  • 32 institutional investors held AIM ImmunoTech (AIM) as of Q4 2024, up from 30 in Q3 2024.
  • Funds reported $919K of AIM ImmunoTech stock for Q4 2024, down 62% quarter-over-quarter.
  • 5 funds opened new AIM ImmunoTech positions in Q4 2024 and 3 closed out, a net change of +2 holders.
  • The largest AIM ImmunoTech buyer in Q4 2024 was Two Sigma Securities, an estimated $16.6K added.
  • The largest AIM ImmunoTech seller in Q4 2024 was Armistice Capital, an estimated $1.17M sold.

Based on aggregated 13F filings for Q4 2024.